Table 4.
Association between the low-dose of alteplase and the risk of sICH
Unadjusted (OR, 95%CI) | p-value | Age- sex- adjusted (OR, 95%CI) | p-value | Multivariable | p-value | |
---|---|---|---|---|---|---|
Age (continuous) | 1.07 (1.03-1.10) | 0.001 | / | / | 1.06 (1.01-1.11) | 0.016 |
Female sex | 1.50 (0.74-3.02) | 0.261 | / | / | 0.81 (0.35-1.85) | 0.614 |
Hyperlipidemia | 0.44 (0.19-1.02) | 0.056 | 0.51 (0.22-1.22) | 0.129 | 0.55 (0.21-1.40) | 0.206 |
Diabetes | 2.03 (0.97-4.24) | 0.060 | 1.80 (0.85-3.82) | 0.125 | 1.09 (0.40-2.96) | 0.878 |
Atrial fibrillation | 6.79 (3.09-14.93) | <0.001 | 5.35 (2.40-11.94) | <0.001 | 3.20 (1.33-7. 70) | 0.009 |
Baseline blood glucose (>10mmol/L) | 2.52 (1.15 - 5.50) | 0.021 | 2.70 (1.21 - 6.02) | 0.015 | 1.93 (0.64 - 5.83) | 0.245 |
Baseline NIHSS score | 1.19 (1.12-1.26) | <0.001 | 1.18 (1.11-1.25) | <0.001 | 1.16 (1.08-1.24) | <0.001 |
Low-dose | 0.251 (0.06-1.07) | 0.02 | 0.17 (0.04-0.76) | 0.02 | 0.13 (0.03-0.62) | 0.010 |
Abbreviations: OR, Odds ratio; CI, confidence interval; NIHSS, national institute of health stroke scale.